Today's post is shared from the nytimes.com As the country struggles to combat the growing abuse of heroin and opioid painkillers, a new battlefield is emerging: the courts. The City of Chicago and two California counties are challenging the drug industry’s way of doing business, contending in two separate lawsuits that “aggressive marketing” by five companies has fueled an epidemic of addiction and cost taxpayers millions of dollars in insurance claims and other health care costs. The severity of drug abuse is well documented: Use of prescription opioids contributed to 16,651 deaths in the United States in 2010 alone, and to an estimated 100,000 deaths in the past decade. When people cannot find or afford prescription painkillers, many have increasingly turned to heroin. The lawsuits assert that drug makers urged doctors to prescribe the drugs far beyond their traditional use to treat extreme conditions, such as acute pain after surgery or injury or cancer pain, while underplaying the high risk of addiction. Such marketing, the plaintiffs say, has contributed to widespread abuse, addiction, overdose and death. Taking the drug makers to court recalls the tobacco liability wars of the 1990s, with government entities suing in the hope of addressing a public health problem and forcing changes from an industry they believed was in denial about the effects of its products. The tobacco settlement led to agreements by the tobacco industry to change marketing practices, which is a goal of the opioid lawsuits. ... |
Copyright
(c) 2010-2024 Jon L Gelman, All Rights Reserved.
Showing posts with label Substance abuse. Show all posts
Showing posts with label Substance abuse. Show all posts
Monday, August 25, 2014
Chicago and 2 California Counties Sue Over Marketing of Painkillers
Tuesday, July 29, 2014
Take Two: Just How Good Are Generic Meds Anyway?
A few days ago I wrote a post about generic painkillers and the fact that doctors themselves—who should know better—often don't use them. "If physicians aren't really sold on generics in their own personal lives," I asked, "does this mean they're not really sold on them in their professional lives too?" Well, perhaps I got it backwards. A friend sent me a link to a Forbes article from last year about the FDA retracting its approval of a generic version of Wellbutrin: The episode is bringing momentum to a movement that has been quietly building among many doctors and medical societies that are increasingly willing to ask a question that borders on heresy: Are generics really identical to the branded products they are meant to replicate? To a surprising degree, they say, the answer is no. |
Related articles
- FDA Closes Down Illegal On-Line Pharmacies (workers-compensation.blogspot.com)
- Addiction Specialists Wary of New Painkiller (workers-compensation.blogspot.com)
- FDA Issues Guidances for Industry on Social Media (workers-compensation.blogspot.com)
- FDA warns of compounded drug recall by Texas firm (workers-compensation.blogspot.com)
- Massachusetts Prohibited From Banning Zogenix (workers-compensation.blogspot.com)
- Leading Coal Industry Law Firm Withheld Evidence of Black Lung Disease (workers-compensation.blogspot.com)
- Its Déjà Vu All Over Again (workers-compensation.blogspot.com)
- FDA Warns Zithromax / Zmax Antibiotics Potential Risk of Fatal Heart Rhythms (workers-compensation.blogspot.com)
Sunday, November 17, 2013
Addiction Specialists Wary of New Painkiller
Addiction experts protested loudly when the Food and Drug Administration approved a powerful new opioid painkiller last month, saying that it would set off a wave of abuse much as OxyContin did when it first appeared.
An F.D.A. panel had earlier voted, 11 to 2, against approval of the drug, Zohydro, in part because unlike current versions of OxyContin, it is not made in a formulation designed to deter abuse.
Now a new issue is being raised about Zohydro. The drug will be manufactured by the same company, Alkermes, that makes a popular medication called Vivitrol, used to treat patients addicted to painkillers or alcohol.
In addition, the company provides financial support to a leading professional group that represents substance abuse experts, the American Society of Addiction Medicine.
For some critics, the company’s multiple roles in the world of painkillers is troubling.
Dr. Gregory L. Jones, an addiction specialist in Louisville, Ky., said he had long been concerned about financial links between the group and the drug industry, adding that the Zohydro situation amplified those potential conflicts.
Dr. Stuart Gitlow, the current president of the American Society of Addiction Medicine, said he had been unaware until now of Alkermes’s involvement with Zohydro. Dr. Gitlow, who is affiliated with Mount Sinai Hospital in New York City, said that the group would seek more information from Alkermes about the situation and then decide what, if anything, to do next.
...
|
Related articles
- F.D.A. Shift on Painkillers Was Years in the Making (workers-compensation.blogspot.com)
- Leading Coal Industry Law Firm Withheld Evidence of Black Lung Disease (workers-compensation.blogspot.com)
- Naloxone Expansion In California Will Enable Family, Friends To Save Lives At Home (workers-compensation.blogspot.com)
- California: Medical Delay and Denial Protested (workers-compensation.blogspot.com)
- Why Tylenol Isn't Always as Safe as People Think (workers-compensation.blogspot.com)
- Expediting Drug Development - The FDA's New "Breakthrough Therapy" Designation (workers-compensation.blogspot.com)
- Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigatio (workers-compensation.blogspot.com)
Wednesday, October 30, 2013
F.D.A. Shift on Painkillers Was Years in the Making
Narcotic pain killers have been the subject of concern and regulation by employers' and their insurance carriers nationally. The evolution of the FDA proposed action to regulate is revealed in today's post is shared from the NYTimes.com
When Heather Dougherty heard the news last week that the Food and Drug Administration had recommended tightening how doctors prescribed the most commonly used narcotic painkillers, she was overjoyed. Fourteen years earlier, her father, Dr. Ronald J. Dougherty, had filed a formal petition urging federal officials to crack down on the drugs. Since then, narcotic painkillers, or opioids, have become the most frequently prescribed drugs in the United States and have set off a wave of misuse, abuse and addiction. Experts estimate that more than 100,000 people have died in the last decade from overdoses involving the drugs. For his part, Dr. Dougherty, who foresaw the problem, retired in 2007 and is now 81 and living in a nursing home. “Too many lives have been ruined,” his daughter said. The story behind the F.D.A.’s turnaround on the pain pills, last Thursday, involved a rare victory by lawmakers from states hard hit by prescription drug abuse over well-financed lobbyists for business and... |
Related articles
- Medical Device Litigation: Medtronic, Inc. v. Stengel (workers-compensation.blogspot.com)
- California: Medical Delay and Denial Protested (workers-compensation.blogspot.com)
- Use Only as Directed (workers-compensation.blogspot.com)
- Huge Differences by Region in Prescribing to Elderly, Study Finds (workers-compensation.blogspot.com)
- Prescription-Drug Coupons - No Such Thing as a Free Lunch (workers-compensation.blogspot.com)
- Lawsuit claims chemical spill at Armstrong caused worker's neurological disorder (workers-compensation.blogspot.com)
Subscribe to:
Posts (Atom)